Kingsview Wealth Management, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Kingsview Wealth Management, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$912,207
+10.7%
8,955
+9.6%
0.03%
+3.1%
Q2 2023$824,238
+26.3%
8,168
+15.2%
0.03%
+18.5%
Q1 2023$652,349
-6.5%
7,091
-7.8%
0.03%
-10.0%
Q4 2022$697,875
+22.2%
7,693
+2.4%
0.03%
+11.1%
Q3 2022$571,000
-12.0%
7,511
-2.1%
0.03%
-12.9%
Q2 2022$649,000
-4.1%
7,676
-0.8%
0.03%
+10.7%
Q4 2021$677,000
+2.6%
7,739
-4.1%
0.03%
-9.7%
Q3 2021$660,000
-7.2%
8,070
+4.0%
0.03%
-11.4%
Q2 2021$711,000
+19.3%
7,759
+12.1%
0.04%
+2.9%
Q1 2021$596,000
+2.6%
6,919
+12.4%
0.03%
-19.0%
Q4 2020$581,000
+4.9%
6,157
-3.3%
0.04%
-16.0%
Q3 2020$554,000
-15.4%
6,369
-15.1%
0.05%
-24.2%
Q2 2020$655,000
-32.5%
7,500
-36.3%
0.07%
-49.6%
Q1 2020$970,000
+51.8%
11,766
+74.3%
0.13%
+63.8%
Q4 2019$639,000
+27.3%
6,749
+16.8%
0.08%
+1.3%
Q3 2019$502,000
+0.4%
5,780
+5.6%
0.08%
-6.0%
Q2 2019$500,000
-13.8%
5,476
-9.2%
0.08%
-4.5%
Q1 2019$580,000
+33.6%
6,029
+19.2%
0.09%
-7.4%
Q4 2018$434,000
+0.7%
5,060
+1.2%
0.10%
+9.2%
Q3 2018$431,000
-15.8%
5,001
-26.2%
0.09%
-28.7%
Q2 2018$512,000
-7.2%
6,778
-0.7%
0.12%
-10.9%
Q1 2018$552,000
+6.2%
6,828
+10.3%
0.14%
-26.3%
Q4 2017$520,000
+76.9%
6,190
+80.7%
0.19%
+44.2%
Q3 2017$294,000
+34.2%
3,426
+30.6%
0.13%
+14.2%
Q2 2017$219,0002,6230.11%
Other shareholders
NOVARTIS A G shareholders Q3 2021
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders